Skip to main content

Chang-guo Zhan

NIH Rank #4569
  • R01 Holder
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6614980Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2025

Linked Award Amount
$2.5M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#4,569
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Chang-guo Zhan. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Chang-guo Zhan as a PI. Multi-PI records show the full award amount for context.

  • 7R01DA035714-12R01
    Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1Tat and cocaine
    $728.6K
    award amount
  • 4UH3NS134920-03UH3
    Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning
    $643.9K
    award amount
  • 5R01DA057866-03R01
    Effects of HIV-1 Tat protein and methamphetamine on VMAT2-mediated dopamine transmission in the context of neuroHIV and drug abuse
    $642.3K
    award amount
  • 4R01DA056646-02R01
    Ghrelin Deacylase as a Treatment for Opioid Polysubstance Abuse
    $506.7K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Chang-guo Zhan as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Kentucky
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5753
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Entered Top 25% Nationally
    Ranked #4569
  7. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  8. 2025
    R01 Grant Holder
  9. 2026
    $5M Cumulative Funding
Chang-guo Zhan | NIH Award Records | ConductScience